Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02959593 · ClinicalTrials.gov registry record · NA
The Effects of Visior on Ocular Hemodynamics
A NA study of Primary Open Angle Glaucoma, sponsored by Visior Technologies.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT02959593 is a NA study of Primary Open Angle Glaucoma that has completed, run by Visior Technologies. The registered enrollment target is 35 participants, below the 293-participant average among 19 other Primary Open Angle Glaucoma trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02959593, a NA study of Primary Open Angle Glaucoma, has completed, sponsored by Visior Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the relationship between the affects of viewing commercially available content through the VISIOR video goggles and ocular blood flow in glaucoma patients and healthy subjects.
Conditions Studied
Interventions
- DEVICE VISIOR video goggles
Study Locations (1)
Indiana
- Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana School of Medicine - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2017-01 |
| Est. Completion | 2017-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02959593
The ClinicalTrials.gov registry entry for NCT02959593 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 293-participant average among 19 other Primary Open Angle Glaucoma trials with a reported enrollment target (88% lower). The listed sponsor is Visior Technologies, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Primary Open Angle Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which VISIOR video goggles is the first listed.
NCT02959593 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT02959593 about?
NCT02959593 is a clinical study titled "The Effects of Visior on Ocular Hemodynamics". To determine the relationship between the affects of viewing commercially available content through the VISIOR video goggles and ocular blood flow in glaucoma patients and healthy subjects.
What is the current status of trial NCT02959593?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2017-01. Estimated completion is 2017-06.
What conditions does trial NCT02959593 study?
This clinical trial studies the following conditions: Primary Open Angle Glaucoma.
What interventions are being tested in trial NCT02959593?
The interventions under investigation include: VISIOR video goggles (DEVICE).
Who is sponsoring clinical trial NCT02959593?
This trial is sponsored by Visior Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02959593 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Open Angle Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hydrus® Microstent New Enrollment Post-Approval Study
RECRUITING · NA
-
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
RECRUITING · NA
-
Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma
RECRUITING · NA
-
Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
RECRUITING · NA
-
Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes
COMPLETED · NA
-
A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.